Deucravacitinib for treating moderate-to-severe plaque psoriasis

Moira Cruickshank, David Cooper, Alan Crozier, Clare Robertson, Lorna Aucott, Paul Manson, Anthony Ormerod, Graham Scotland, Miriam Brazzelli* (Corresponding Author)

*Corresponding author for this work

Research output: Book/ReportCommissioned Report

Abstract

Evidence Review Group report in support of NICE STA Programme, [ID3859]
Original languageEnglish
PublisherEvidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence
Number of pages155
Publication statusPublished - 5 Jun 2023

Bibliographical note

Source of funding: This report was commissioned by the NIHR Systematic Reviews Programme as project number 135613.

Fingerprint

Dive into the research topics of 'Deucravacitinib for treating moderate-to-severe plaque psoriasis'. Together they form a unique fingerprint.

Cite this